Investing.com - Financial Markets Worldwide
🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

Bionano Genomics Inc (0A4K)

London
Symbol
Exchange
Currency
BNGONASDAQUSD
0A4KLondonUSD
BNGOBIVAMXN
Currency in USD
0.24
0.00(0.00%)
Real-time Data
0A4K Scorecard
Full Analysis
3 analysts have revised their earnings upwards for the upcoming period
Fair Value
Unlock Value
Day's Range
0.230.24
52 wk Range
0.202.26
Key Statistics
Edit
Prev. Close
1.17
Open
0.24
Day's Range
0.23-0.24
52 wk Range
0.2-2.26
Volume
-
Average Volume (3m)
101.02K
1-Year Change
-82.86%
Book Value / Share
0.57
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0A4K Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Technical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
1.00
Upside
+322.65%
Members' Sentiments
Bearish
Bullish
ProTips
pro lock
Unlock All 13
Quickly burning through cash
Unlock InvestingPro

Bionano Genomics Inc News & Analysis

Show more

Bionano Genomics Inc Company Profile

Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA. The company also provides Saphyr and Bionano compute servers; and VIA software, which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Industry
Healthcare Equipment & Supplies
Sector
Healthcare
Employees
344
Market
United States

Compare 0A4K to Peers and Sector

Metrics to compare
0A4K
Peers
Sector
Relationship
P/E Ratio
−0.2x−4.7x−0.6x
PEG Ratio
0.00−0.270.00
Price/Book
0.5x2.2x2.6x
Price / LTM Sales
0.7x4.1x3.2x
Upside (Analyst Target)
-31.4%45.4%
Fair Value Upside
Unlock−0.1%7.7%Unlock

FAQ

What Is the Bionano Genomics (0A4K) Stock Price Today?

The Bionano Genomics stock price today is 0.24

What Stock Exchange Does Bionano Genomics Trade On?

Bionano Genomics is listed and trades on the London stock exchange.

What Is the Stock Symbol for Bionano Genomics?

The stock symbol for Bionano Genomics is "0A4K."

What Is the Bionano Genomics Market Cap?

As of today, Bionano Genomics market cap is 24.19M.

What is Bionano Genomics Earnings Per Share?

The Bionano Genomics EPS is -2.21.

From a Technical Analysis Perspective, Is 0A4K a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.